Posted 15 July, 2007 - 10:44 by steve
Posted 27 April, 2007 - 12:37 by steve
This website [url=http://www.osteoporosis.ca/english/News/GuidelinesNewsRelease/]ostroporosis.ca [/url]said :The Osteoporosis Society of Canada (OSC) has launched the first evidence-based clinical practice guidelines for osteoporosis in the world.
it also mentions
[quote]Prevention and Treatment
Higher intakes of calcium and vitamin D are recommended, particularly in adults over 50 (calcium 1500 mg/day and vitamin D 800 IU/day).
Children, particularly those entering and passing through puberty, should participate in impact exercise or sports (mainly field and court sports).
Men and women throughout life should participate in exercise, particularly weight-bearing exercises such as brisk walking, running or dancing.
Bisphosphonates (Didrocal, Fosamax and Actonel) and raloxifene (Evista) are first choice therapies for individuals without menopausal (vasomotor) symptoms. Hormone Replacement Therapy (HRT) is no longer the "gold standard" for treatment of osteoporosis.
Posted 27 April, 2007 - 10:54 by steve
Fall is one of the major causes of mobidity and mortality in the elderly. The most effective intervention was a multifactorial falls risk assessment and management programme. It is a research trial in 2004
[url=http://www.bmj.com/cgi/content/abridged/328/7441/680?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=fall&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT]go to BMJ[/url]
Posted 25 April, 2007 - 14:54 by steve
Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery
New NICE guide line : April 2007
[url=http://www.nice.org.uk/CG46]Click here[/url]
Posted 15 April, 2007 - 11:17 by steve
My consultant neurologist normally prescribes the patients with stroke: Aspirin, Ramipril,Statin.This ESPS-2 shows there is a benefit of adding dipyridamole. It was done in 1988. so there should be more research data somewhere.
[b]European Stroke Prevention Study 2 (ESPS-2):[/b]
After doing randomised, double-blind, placebo-controlled trial of 6602 patients, it was discovered that the 24-month stroke rate was 12.9% in the aspirin-alone group, 13.2% in the dipyridamole-alone group, 9.9% in the combination group and 15.8% in the placebo group.
Stroke risk was significantly reduced by 18.1% in the aspirin-alone group, by 16.3% in the dipyridamole-alone group, and by 37.0% in the combination group compared to the placebo group. The results regarding the endpoint of stroke or death were similar but there was no significant difference among the groups for the endpoint of death .
[url=http://www.ncbi.nlm.nih.gov]source[/url]
Posted 12 February, 2007 - 12:39 by steve
This is the guide lines for Early Management of Suspected Bacterial Meningitis and Meningococcal Septicaemia in Immunocompetent Adults
[url=http://www.britishinfectionsociety.org/Adult_men_early_poster%202004.pdf]Click here[/url]
Posted 12 February, 2007 - 12:05 by steve
Clinical management of patients with an
influenza-like illness during an influenza pandemic
Provisional guidelines from the
British Infection Society
British Thoracic Society
Health Protection Agency
in collaboration with the Department of Health
Version 11, updated on 2 October 2006
[url=http://www.britishinfectionsociety.org/Pandemic%20guidelines%202007.pdf]Guidelines[/url]
Posted 31 January, 2007 - 17:21 by steve
This is not exciting but interesting topic. I think. You may check
[url=http://www.onmedica.net/content.asp?t=2&c=4462&pid=84cdcccdcccec6c9bbd2c8bccfcfd2cbbbbdced2c6bbc6bcd2becfcebecdbac8beccb9c6c882]here[/url]
Posted 30 January, 2007 - 19:09 by steve
| Age ≥ 65 years? |
1 |
| > 3 Risk Factors for CAD? |
1 |
| Known CAD (stenosis ≥ 50%)? |
1 |
| ASA Use in Past 7d? |
1 |
| Severe angina (≥ 2 episodes w/in 24 hrs)? |
1 |
| ST changes ≥ 0.5mm? |
1 |
| + Cardiac Marker? |
1 |
Risk Factors:
Posted 30 January, 2007 - 12:58 by steve
Postoperative gemcitabine significantly delayed the development of recurrent disease after complete resection of pancreatic cancer compared with observation alone. These results support the use of gemcitabine as adjuvant chemotherapy in resectable carcinoma of the pancreas.
[url=http://jama.ama-assn.org/cgi/content/abstract/297/3/267]Full article on JAMA[/url]
